Ledger.Open graph →
SEC Form D · filed April 28, 2020

INVIVO THERAPEUTICS HOLDINGS CORP

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

C. A. Merrifield · Cambridge, MADirectorRichard A. Roberts · Cambridge, MADirectorRichard Toselli · Cambridge, MAExec · DirectorRichard Christopher · Cambridge, MAExecRobert A. Rosenthal · Cambridge, MADirectorChristina A. Morrison · Cambridge, MADirectorDaniel A. Marshak · Cambridge, MADirectorMatthew B. Ruesch · McLean, VADirectorSteven T. Berg · Waltham, MADirectorJoshua T. Weisenbeck · New York, NYDirectorBrandon T. Brahm · New York, NYExec · DirectorClaudio D. Ruben · Santa Fe, NMDirectorTerry D. Borst · Atascadero, CADirectorJuan M. Hill · Waltham, MAExecSarah Tavel · New York, NYDirectorMichael Vela · Chesterfield, MODirectorJeff Smith · Chesterfield, MOExecPortage Ventures III GP Inc · Toronto, Ontario, CanadaDirectorStalin Ramirez · Fair Lawn, NJExec · DirectorShaheed Bailey · Clifton, NJDirectorCary G. Marr · George Town, Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗